Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
podophyllotoxin
- Development stage
- Unknown
- Lead developer
- Phoenix Laboratories
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Wartec is a topical antimitotic and cytotoxic formulation containing podophyllotoxin (also known as podofilox), a naturally occurring lignan extracted from the roots and rhizomes of *Podophyllum* plants. It is approved for the treatment of external condylomata acuminata (genital warts) affecting the penis or external female genitalia. Wartec works by binding to tubulin, thereby preventing microtubule assembly and arresting cell division in the metaphase. This local cytotoxic action leads to necrosis of the rapidly proliferating, virus-infected wart tissue. Originally developed by Stiefel Laboratories (which was acquired by GSK), the product is currently marketed and distributed in various regions by companies including Phoenix Laboratories.
- Brand names
- WartecWarticon
- Other names
- podofiloxpodophyllotoxin
02
Targets
TUBB (Tubulin (alpha and beta subunits))
Beyond the preview
Go deeper on podophyllotoxin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on podophyllotoxin.